Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 02-Feb-24 4:05 PM View:  | Travere Therapeutics, Inc. (TVTX) | 01-Feb-24 | Sale | 2,820 | $8.53 | $24,058.00 | (5%) 54.84K to 52.02K | |
| 02-Feb-24 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 31-Jan-24 | Grant | 13,500 | -- | -- | 33% 41.34K to 54.84K | |
| 25-Jan-24 4:10 PM View: | Travere Therapeutics, Inc. (TVTX) | 23-Jan-24 | Sale | 910 | $9.07 | $8,252.24 | (2%) 42.25K to 41.34K | |
| 12-May-23 4:06 PM View: | Travere Therapeutics, Inc. (TVTX) | 11-May-23 | Sale (Planned) | 122 | $16.12 | $1,966.64 | (< 1%) 42.37K to 42.25K | |
| 12-May-23 4:06 PM View: | Travere Therapeutics, Inc. (TVTX) | 10-May-23 | Sale | 436 | $16.59 | $7,233.24 | (1%) 42.8K to 42.37K | |
| 02-Feb-23 6:53 PM View: | Travere Therapeutics, Inc. (TVTX) | 02-Feb-23 | Sale (Planned) | 360 | $22.42 | $8,071.20 | (< 1%) 43.16K to 42.8K | |
| 02-Feb-23 6:53 PM View: | Travere Therapeutics, Inc. (TVTX) | 01-Feb-23 | Sale | 1,671 | $21.75 | $36,347.60 | (4%) 44.84K to 43.16K | |
| 02-Feb-23 6:53 PM View: | Travere Therapeutics, Inc. (TVTX) | 31-Jan-23 | Grant | 10,000 | -- | -- | 29% 34.84K to 44.84K | |
| 26-Jan-23 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 25-Jan-23 | Sale (Planned) | 192 | $21.63 | $4,152.96 | (< 1%) 35.03K to 34.84K | |
| 26-Jan-23 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 24-Jan-23 | Sale | 905 | $21.90 | $19,823.50 | (3%) 35.93K to 35.03K | |
| 15-Sep-22 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 13-Sep-22 | Market Sale | 349 | $28.00 | $9,772.00 | (< 1%) 36.28K to 35.93K | (< 1%) |
| 12-May-22 8:44 PM View: | Travere Therapeutics, Inc. (TVTX) | 11-May-22 | Sale | 445 | $21.92 | $9,755.96 | (1%) 36.18K to 35.73K | |
| 12-May-22 8:44 PM View: | Travere Therapeutics, Inc. (TVTX) | 10-May-22 | Sale | 436 | $21.51 | $9,378.36 | (1%) 36.61K to 36.18K | |
| 02-Feb-22 4:22 PM View: | Travere Therapeutics, Inc. (TVTX) | 31-Jan-22 | Grant | 8,750 | -- | -- | 31% 28.66K to 37.41K | |
| 02-Feb-22 4:22 PM View: | Travere Therapeutics, Inc. (TVTX) | 31-Jan-22 | Sale | 798 | $26.51 | $21,151.70 | (2%) 37.41K to 36.61K | |
| 26-Jan-22 4:38 PM View: | Travere Therapeutics, Inc. (TVTX) | 24-Jan-22 | Market Sale | 934 | $24.58 | $22,954.60 | (3%) 29.6K to 28.66K | (14%) |